Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.13
-0.28-1.82%
Last update: Oct 2, 4:00 PM
$15.13
-0.28-1.82%
Delcath Systems Inc (DCTH) Stock Price, Quote, News & History
DCTHNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Delcath Systems (NASDAQ:DCTH) through any online brokerage.
Other companies in Delcath Systems’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Delcath Systems has a consensus price target of $22.60.
The stock price for Delcath Systems (NASDAQ: DCTH) is $15.13 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Delcath Systems.
Delcath Systems does not have any upcoming earnings scheduled.
There is no upcoming split for Delcath Systems.
Delcath Systems is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
